Pristiq — Class II drug recall D-1409-2014
Terminated recall by Pfizer Us Pharmaceutical Group, reported 2014-07-02, distributed nationwide. Presence of Foreign Tablets/Capsules: Pfizer is recalling 50 mg Pristiq (desvenlafaxine) extended release tabl
| Recall number | D-1409-2014 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Pfizer Us Pharmaceutical Group, New York, NY, United States |
| Recall initiated | 2014-04-16 |
| Classified | 2014-06-24 |
| Reported by FDA | 2014-07-02 |
| Terminated | 2016-09-20 |
| Distributed | Nationwide (US) |
| Quantity | 220,761 bottles |
| NDC | 00008-1210, 00008-1210-30, 00008-1211, 00008-1211-01, 00008-1211-14, 00008-1211-30, 00008-1211-50, 00008-1222, 00008-1222-01, 00008-1222-14, 00008-1222-30, 00008-1222-50 |
Product
Pristiq (desvenlafaxine) Extended-Release Tablets 50 mg, 30 count bottle, Rx only, Distributed by Wyeth Pharmaceuticals, Inc., NDC 0008-1211-30
Reason for recall
Presence of Foreign Tablets/Capsules: Pfizer is recalling 50 mg Pristiq (desvenlafaxine) extended release tablets because a single Pristiq 100 mg tablet was found in a bottle of 50 mg Pristiq.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1409-2014. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.